Literature DB >> 27503319

Transient modulation of calcium and parathyroid hormone stimulates bone formation.

Andy B Chen1, Kazumasa Minami2,3, João F Raposo4, Nariaki Matsuura5, Masahiko Koizumi3, Hiroki Yokota6, Hugo G Ferreira7.   

Abstract

Intermittent administration of parathyroid hormone can stimulate bone formation. Parathyroid hormone is a natural hormone that responds to serum calcium levels. In this study, we examined whether a transient increase and/or decrease in the serum calcium can stimulate bone formation. Using a mathematical model previously developed, we first predicted the effects of administration of parathyroid hormone, neutralizing parathyroid hormone antibody, calcium, and EGTA (calcium chelator) on the serum concentration of parathyroid hormone and calcium. The model predicted that intermittent injection of parathyroid hormone and ethylene glycol tetraacetic acid transiently elevated the serum parathyroid hormone, while that of parathyroid hormone antibody and calcium transiently reduced parathyroid hormone in the serum. In vitro analysis revealed that parathyroid hormone's transient changes (both up and down) elevated activating transcription factor 4-mediated osteocalcin expression. In the mouse model of osteoporosis, both intermittent administration of calcium and ethylene glycol tetraacetic acid showed tendency to increase bone mineral density of the upper limb (ulna and humerus) and spine, but the effects varied in a region-specific manner. Collectively, the study herein supports a common bone response to administration of calcium and its chelator through their effects on parathyroid hormone.

Entities:  

Keywords:  Bone; Calcium; EGTA; Osteoblast; Parathyroid hormone

Mesh:

Substances:

Year:  2016        PMID: 27503319     DOI: 10.1007/s12020-016-1066-7

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  25 in total

1.  The Effects of Parathyroid Hormone and Calcium Gluconate on the Skeletal Tissues of Mice.

Authors:  M Silberberg; R Silberberg
Journal:  Am J Pathol       Date:  1943-09       Impact factor: 4.307

2.  A control engineering model of calcium regulation.

Authors:  Christopher R Christie; Luke E K Achenie; Babatunde A Ogunnaike
Journal:  J Clin Endocrinol Metab       Date:  2014-04-14       Impact factor: 5.958

3.  Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells.

Authors:  H Dobnig; R T Turner
Journal:  Endocrinology       Date:  1995-08       Impact factor: 4.736

4.  A mathematical model of calcium and phosphorus metabolism in two forms of hyperparathyroidism.

Authors:  J F Raposo; A Pires; H Yokota; H G Ferreira
Journal:  Endocrine       Date:  2011-08-27       Impact factor: 3.633

Review 5.  Parathyroid hormone and parathyroid hormone-related peptide, and their receptors.

Authors:  Robert C Gensure; Thomas J Gardella; Harald Jüppner
Journal:  Biochem Biophys Res Commun       Date:  2005-03-18       Impact factor: 3.575

6.  Safety and efficacy of regional citrate anticoagulation during 8-hour sustained low-efficiency dialysis.

Authors:  John A Clark; Gerald Schulman; Thomas A Golper
Journal:  Clin J Am Soc Nephrol       Date:  2008-02-13       Impact factor: 8.237

7.  Treatment of moderate to severe acute hypocalcemia in critically ill trauma patients.

Authors:  Roland N Dickerson; Laurie M Morgan; Martin A Croce; Gayle Minard; Rex O Brown
Journal:  JPEN J Parenter Enteral Nutr       Date:  2007 May-Jun       Impact factor: 4.016

8.  A new method for in vivo analysis of parathyroid hormone-calcium set point in mice.

Authors:  Yasuo Imanishi; Charles Hall; Marilyn Sablosky; Edward M Brown; Andrew Arnold
Journal:  J Bone Miner Res       Date:  2002-09       Impact factor: 6.741

Review 9.  Calcium use in the management of osteoporosis: continuing questions and controversies.

Authors:  Cory Wilczynski; Pauline Camacho
Journal:  Curr Osteoporos Rep       Date:  2014-12       Impact factor: 5.096

10.  Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. A putative explanation for why intermittent administration is needed for bone anabolism.

Authors:  Teresita Bellido; A Afshan Ali; Lilian I Plotkin; Qiang Fu; Igor Gubrij; Paula K Roberson; Robert S Weinstein; Charles A O'Brien; Stavros C Manolagas; Robert L Jilka
Journal:  J Biol Chem       Date:  2003-10-01       Impact factor: 5.157

View more
  4 in total

Review 1.  The guiding role of bone metabolism test in osteoporosis treatment.

Authors:  Wei Zhang; Guo-Ji Yang; Shi-Xian Wu; Dong-Qing Li; Ying-Bo Xu; Cheng-Hong Ma; Jun-Ling Wang; Wei-Wen Chen
Journal:  Am J Clin Exp Immunol       Date:  2018-04-05

2.  Decrease in leptin mediates rat bone metabolism impairments during high-fat diet-induced catch-up growth by modulating the OPG/RANKL balance.

Authors:  Xiaoling Liu; Yuzhen Liang; Ning Xia; Weiming Liu; Qiong Yang; Caimei Wang
Journal:  3 Biotech       Date:  2021-01-30       Impact factor: 2.406

3.  Loss of Bone Mineral Density Associated with Age in Male Rats Fed on Sunflower Oil Is Avoided by Virgin Olive Oil Intake or Coenzyme Q Supplementation.

Authors:  Alfonso Varela-López; Julio J Ochoa; José M Llamas-Elvira; Magdalena López-Frías; Elena Planells; Lorenza Speranza; Maurizio Battino; José L Quiles
Journal:  Int J Mol Sci       Date:  2017-06-29       Impact factor: 5.923

4.  Age-Related Loss in Bone Mineral Density of Rats Fed Lifelong on a Fish Oil-Based Diet Is Avoided by Coenzyme Q10 Addition.

Authors:  Alfonso Varela-López; Julio J Ochoa; José M Llamas-Elvira; Magdalena López-Frías; Elena Planells; MCarmen Ramirez-Tortosa; Cesar L Ramirez-Tortosa; Francesca Giampieri; Maurizio Battino; José L Quiles
Journal:  Nutrients       Date:  2017-02-22       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.